Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients.

Leukemia · 2021 · PMC8102180 · PMID 33623138

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significancep = 0.06so close (0.05 < p ≤ 0.1)

4B ), this did not reach statistical significance (median time to progression of 22.1 versus 26.8 months, respectively, p = 0.06).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.